Mode
Text Size
Log in / Sign up

Poor glycemic control in Type 2 Diabetes is associated with lower FEV1 and FVC volumesPoor blood sugar control linked to lower lung function in diabetes

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that poor glycemic control in Type 2 Diabetes is associated with lower absolute lung volumes (FEV1 and FVC).

This meta-analysis synthesizes data from observational studies to evaluate the relationship between glycemic control (HbA1c) and spirometric outcomes in adults with Type 2 Diabetes Mellitus. The analysis compared patients with good glycemic control against those with poor glycemic control.

The primary findings indicate that the poor HbA1c group had significantly lower FEV1 (-0.16 L; 95% CI -0.25 to -0.07; p < 0.001) and reduced FVC (-0.24 L; 95% CI -0.35 to -0.14; p < 0.001). The FEV1/FVC ratio was slightly higher in the poor-control group by 1.61 percentage points (95% CI 0.50 to 2.73; p = 0.005).

The authors note limitations including the reliance on observational studies and the use of absolute spirometric values. Because the FEV1/FVC ratio was slightly higher in those with poor control, the data suggest a reduction in overall lung volumes rather than specific obstructive impairment. Clinical application is limited by the lack of evidence for causality.

How this fits prior evidence

This meta-analysis addresses a gap regarding the pulmonary impact of glycemic control in Type 2 Diabetes Mellitus. It builds upon prior coverage noting that COPD patients have higher odds of diabetes mellitus (OR 1.39) and that culturally tailored interventions can successfully decrease HbA1c levels. While previous data showed no significant link from diabetes to COPD, this study specifically quantifies the association between poor HbA1c and reduced FEV1 and FVC volumes.

Managing blood sugar is a cornerstone of life with type 2 diabetes, but its impact on other parts of the body is still being explored. New data suggests that how well you manage your glucose levels might be linked to your lung function.

Researchers looked at adults with type 2 diabetes and compared those with good blood sugar control to those with poor control. They found that people with poor control had lower FEV1 and FVC values. These are measurements of how much air you can breathe out during a test. Specifically, the group with poorer control showed a decrease in these lung volumes.

While the data shows a link between blood sugar and lung volume, it does not prove that one causes the other. The findings are based on observational studies, meaning we cannot say for certain that poor sugar levels directly cause lung issues. However, the results suggest that maintaining steady blood sugar levels is important for overall respiratory health.

What this means for you:
People with type 2 diabetes and poorly managed blood sugar may have lower lung volumes.

Common questions

How does blood sugar affect the lungs in people with diabetes?

The study found that adults with type 2 diabetes who had poor glycemic control (blood sugar) showed lower FEV1 and FVC values. These are measurements of how much air you can move out of your lungs. While it shows a link, the data is based on observational studies rather than a direct cause.

What do FEV1 and FVC mean for my lung health?

FEV1 and FVC are ways doctors measure how much air your lungs can hold and move. The study found that those with poor blood sugar control had lower values in both areas, meaning they moved less air during testing than those with good blood sugar management.

Does this mean my diabetes is causing lung disease?

The study shows an association between poor blood sugar and lower lung volumes, but it does not confirm a specific type of lung disease or impairment. Because the data comes from observational studies, you should talk to your doctor about what these results mean for your specific health.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJan 2026
View Original Abstract ↓
BACKGROUND: The lung, although not traditionally been considered a target organ in diabetes, may undergo microvascular and connective tissue changes that are related to poor glycemic control. This systematic review and meta-analysis aimed to systematically evaluate and quantify the association between HbA1c values and pulmonary function in adults with type 2 diabetes mellitus. METHODS: A systematic review was conducted in accordance with the PRISMA 2020 guidelines. Studies were searched in PubMed/MEDLINE, Scopus, and Web of Science Core Collection from database inception to 25 December 2025. Eligible studies compared spirometric outcomes between adults with type 2 diabetes categorized as having good versus poor glycemic control based on HbA1c. Random-effects meta-analyses were conducted using mean differences. RESULTS: Individuals with poor glycemic control had significantly lower absolute spirometric volumes. FEV1 was lower in the poor HbA1c group, with a pooled mean difference of -0.16 L (95% CI -0.25 to -0.07; p < 0.001). Similarly, FVC was reduced, with a pooled mean difference of -0.24 L (95% CI -0.35 to -0.14; p < 0.001). In contrast, the FEV1/FVC ratio was slightly higher in the poor-control group (MD = 1.61 percentage points, 95% CI 0.50 to 2.73; p = 0.005). All pooled analyses showed no evidence of statistical heterogeneity (I2 = 0%). CONCLUSION: Poor glycemic control in T2DM is associated with lower absolute FEV1 and FVC. The preserved or slightly higher FEV1/FVC ratio suggests reduced spirometric volumes rather than definite obstructive impairment. These findings should be interpreted as group-level associations because the analyses were based on absolute spirometric values and observational studies.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.